Oral Hypoglycemic Agents in Pregnancy

Obstetrics and Gynecology Clinics of North America

Volumn 38, Issue 2, 2011, Pages 227-234

  Refuerzo, Jerrie S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Diabetes mellitus; Hypoglycemic agents; Pregnancy

Indexed keywords

CHLORPROPAMIDE; GLIBENCLAMIDE; GLIPIZIDE; INSULIN; METFORMIN; PLACEBO; TOLBUTAMIDE;

BREAST FEEDING; CONCENTRATION RESPONSE; COST BENEFIT ANALYSIS; DIARRHEA; DRUG ABSORPTION; DRUG COST; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; DYSPEPSIA; ERYTHEMA; FLATULENCE; HUMAN; HYPOGLYCEMIA; LACTIC ACIDOSIS; LIVER FUNCTION TEST; MACULOPAPULAR RASH; MEASLES LIKE RASH; NAUSEA; NAUSEA AND VOMITING; NONHUMAN; PATIENT COMPLIANCE; PATIENT SATISFACTION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; PRURITUS; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; URTICARIA; VOMITING;

ADMINISTRATION, ORAL; BREAST FEEDING; DIABETES, GESTATIONAL; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; PREGNANCY; TREATMENT OUTCOME;

EID: 79955948547     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2011.02.013     Document Type: Review

References (45)

1. Gabbe S., Graves C.R. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol 2003, 102(4):857-868.
2. ACOG practice bulletin 30 2001, American College of Obstetricians and Gynecologists, ACOG, Washington, DC.
3. Norman R.J., Wang J.X., Hague W. Should we continue or stop insulin-sensitizing drugs during pregnancy?. Curr Opin Obstet Gynecol 2004, 16(3):245-250.
4. Ehrenberg H.M., Durnwald C.P., Catalano P., et al. The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol 2004, 191(3):969-974.
5. Ehrenberg H.M., Mercer B.M., Catalano P.M. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 2004, 191(3):964-968.
6. Martorell S., Schroeder D.G. Early nutrition and later adiposity. J Nutr 2001, 131:874S-880S.
7. Strauss R. Effects of intrauterine environment on childhood growth. Br Med Bull 1997, 53(1):85-95.
8. Whitaker R., Dietz W.H. Role of the prenatal environment in the development of obesity. J Pediatr 1998, 135(5):768-776.
9. Jovanovic R., Jovanovic L. Obstetric management when normaolgycemia is maintained in diabetic pregnant women with vascular compromise. Am J Obstet Gynecol 1984, 149(6):617-623.
10. Metzger B.E., Lowe L.P., Dyer A.R., et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008, 358(19):1991-2002.
11. Prendergast B.D. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents. Clin Pharm 1984, 3(5):473-485.
12. Merlob P., Levitt O., Stahl B. Oral antihyperglycemic agents during pregnancy and lactation: a review. Paediatr Drugs 2002, 4(11):755-760.
13. Sivan E., Feldman B., Dolitzki M., et al. Glyburide crosses the placenta in vivo in pregnant rats. Diabetologia 1995, 38(7):753-756.
14. Elliott B.D., Langer O., Schenker S., et al. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 1991, 165:807-812.
15. Elliott B.D., Schenker S., Langer O., et al. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 1994, 171(3):653-660.
16. Koren G. Glyburide and fetal safety; transplacental pharmacokinetic considerations. Reprod Toxicol 2001, 15(3):227-229.
17. Garcia-Bournissen F., Feig D.S., Koren G. Maternal-fetal transport of hypoglycaemic drugs. Clin Pharmacokinet 2003, 42(4):303-313.
18. Langer O., Conway D.L., Berkus M.D., et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000, 343(16):1134-1138.
19. Lim J.M., Tayob Y., O'Brien P.M., et al. A comparison between the pregnancy outcome of women with gestation diabetes treated with glibenclamide and those treated with insulin. Med J Malaysia 1997, 52(4):377-381.
20. Goetzl L., Wilkins I. Glyburide compared to insulin for the treatment of gestational diabetes mellitus: a cost analysis. J Perinatol 2002, 22(5):403-406.
21. Nicholson W., Bolen S., Witkop C.T., et al. Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol 2009, 113(1):193-205.
22. Anjalakshi C., Balaji V., Balaji M.S., et al. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Res Clin Pract 2007, 76(3):474-475.
23. Bertini A.M., Silva J.C., Taborda W., et al. Perinatal outcomes and the use of oral hypoglycemic agents. J Perinat Med 2005, 33(6):519-523.
24. Conway D., Gonzales O., Skiver D. Use of glyburide for the treatment of gestational diabetes: the san antonio experience. Obstet Gynecol Surv 2004, 59(7):491-493.
25. Feig D.S., Briggs G.G., Kraemer J.M., et al. Transfer of glyburide and glipizide into breast milk. Diabetes Care 2005, 28(8):1851-1855.
26. Glatstein M.M., Djokanovic N., Garcia-Bournissen F., et al. Use of hypoglycemic drugs during lactation. Can Fam Physician 2009, 55(4):371-373.
27. Coetzee E.J., Jackson W.P. Pregnancy in established non-insulin-dependent diabetics. A five-and-a-half year study at Groote Schuur Hospital. S Afr Med J 1980, 58(20):795-802.
28. Coetzee E.J., Jackson W.P. Oral hypoglycaemics in the first trimester and fetal outcome. S Afr Med J 1984, 65(16):635-637.
29. Coetzee E.J., Jackson W.P. The management of non-insulin-dependent diabetes during pregnancy. Diabetes Res Clin Pract 1986, 1:281-287.
30. Hellmuth E., Damm P., Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med 2000, 17(7):507-511.
31. Checa M.A., Requena A., Salvador C., et al. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome. Hum Reprod Update 2005, 11(4):375-390.
32. Glueck C.J., Bornovali S., Pranikoff J., et al. Metformin, preeclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. Diabet Med 2004, 21(8):829-836.
33. Glueck C.J., Wang P., Goldenberg N., et al. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002, 17(11):2858-2864.
34. Glueck C.J., Goldenberg N., Pranikoff J., et al. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 2004, 19(6):1323-1330.
35. Vanky E., Salvesen K.A., Heimstad R., et al. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 2004, 19(8):1734-1740.
36. Glueck C.J., Wang P., Kobayashi S., et al. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002, 77(3):520-525.
37. Rowan J.A., Hague W.M., Gao W., et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008, 358(19):2003-2015.
38. Kovo M., Haroutiunian S., Feldman N., et al. Determination of metformin transfer across the human placenta using a dually perfused ex vivo placental cotyledon model. Eur J Obstet Gynecol Reprod Biol 2008, 136(1):29-33.
39. Nanovskaya T.N., Nekhayeva I.A., Patrikeeva S.L., et al. Transfer of metformin across the dually perfused human placental lobule. Am J Obstet Gynecol 2006, 195(4):1081-1085.
40. Glueck C.J., Goldenberg N., Streicher P., et al. Metformin and gestational diabetes. Curr Diab Rep 2003, 3(4):303-312.
41. Bolen S., Feldman L., Vassy J., et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007, 147(6):386-399.
42. Asche C.V., McAdam-Marx C., Shane-McWhorter L., et al. Association between oral antidiabetic use, adverse events, and outcomes in patients with type 2 diabetes. Diabetes Obes Metab 2008, 10(8):638-645.
43. Briggs G.G., Ambrose P.J., Nageotte M.P., et al. Excretion of metformin into breast milk and the effect on nursing infants. Obstet Gynecol 2005, 105(6):1437-1441.
44. Gardiner S.J., Kirkpatrick C.M., Begg E.J., et al. Transfer of metformin into human milk. Clin Pharmacol Ther 2003, 73(1):71-77.
45. Hale T.W., Kristensen J.H., Hackett L.P., et al. Transfer of metformin into human milk. Diabetologia 2002, 45(11):1509-1514.